Your browser doesn't support javascript.
loading
Immunogenicity of Infliximab Among Patients With Behçet Syndrome: A Controlled Study.
Esatoglu, Sinem Nihal; Akkoc-Mustafayev, Fatma Nihan; Ozguler, Yesim; Ozbakir, Fatma; Nohut, Okan K; Cevirgen, Dilsen; Hamuryudan, Vedat; Hatemi, Ibrahim; Celik, Aykut Ferhat; Yazici, Hasan; Hatemi, Gulen.
Afiliação
  • Esatoglu SN; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Akkoc-Mustafayev FN; Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ozguler Y; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Ozbakir F; Central Research Laboratory, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Nohut OK; Central Research Laboratory, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Cevirgen D; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Hamuryudan V; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Hatemi I; Division of Gastroenterology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Celik AF; Division of Gastroenterology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Yazici H; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Hatemi G; Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical School, Istanbul University-Cerrahpasa, Istanbul, Turkey.
Front Immunol ; 11: 618973, 2020.
Article em En | MEDLINE | ID: mdl-33414791

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-Idiotípicos / Síndrome de Behçet / Antirreumáticos / Infliximab Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Anti-Idiotípicos / Síndrome de Behçet / Antirreumáticos / Infliximab Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Revista: Front Immunol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia País de publicação: Suíça